Stocks
Health Care
dmra
Damora Therapeutics
NASDAQ: DMRA
-0.22 (-0.76%)
28.69
USD
At close at Mar 20, 20:44 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-22.26M
Pretax Income
-15.85M
Net Income
-21.44M
EBITDA
-21.22M
EBIT
-21.40M
Earnings Per Share
-18.67
Balance Sheet
Cash & Cash Equivalents
19.45M
Total Debt
15.25K
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
22.13M
Book Value Per Share
19.36
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.